These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 19345423

  • 1. Evaluation of a multiplex bead-based screening assay for detection of binding antibodies to interferon-beta.
    Lapé Nixon M, Matud J, Yeh C, Prince HE.
    J Neuroimmunol; 2009 May 29; 210(1-2):104-7. PubMed ID: 19345423
    [Abstract] [Full Text] [Related]

  • 2. Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera.
    Prince HE, Lapé-Nixon M, Audette C, Van Horn K.
    J Neuroimmunol; 2007 Oct 29; 190(1-2):165-9. PubMed ID: 17889376
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
    Gneiss C, Tripp P, Ehling R, Khalil M, Lutterotti A, Egg R, Mayringer I, Künz B, Berger T, Reindl M, Deisenhammer F.
    J Neuroimmunol; 2006 May 29; 174(1-2):174-9. PubMed ID: 16556466
    [Abstract] [Full Text] [Related]

  • 6. The importance of measuring IFNbeta bioactivity: monitoring in MS patients and the effect of anti-IFNbeta antibodies.
    Pachner AR, Dail D, Pak E, Narayan K.
    J Neuroimmunol; 2005 Sep 29; 166(1-2):180-8. PubMed ID: 16005084
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients.
    Lam R, Farrell R, Aziz T, Gibbs E, Giovannoni G, Grossberg S, Oger J.
    J Immunol Methods; 2008 Jul 31; 336(2):113-8. PubMed ID: 18511063
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-interferon-beta neutralising activity is not entirely mediated by antibodies.
    Gilli F, Marnetto F, Caldano M, Valentino P, Granieri L, Di Sapio A, Capobianco M, Sala A, Malucchi S, Kappos L, Lindberg RL, Bertolotto A.
    J Neuroimmunol; 2007 Dec 31; 192(1-2):198-205. PubMed ID: 17950468
    [Abstract] [Full Text] [Related]

  • 12. Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
    Hesse D, Sellebjerg F, Sorensen PS.
    Neurology; 2009 Aug 04; 73(5):372-7. PubMed ID: 19652141
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of four different assays for the detection of binding antibodies against interferon-beta.
    Gneiss C, Brugger M, Millonig A, Fogdell-Hahn A, Rudzki D, Hillert J, Berger T, Reindl M, Deisenhammer F.
    Mult Scler; 2008 Jul 04; 14(6):830-6. PubMed ID: 18535018
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The IgG subclass-specificities of anti-IFNbeta antibodies change with time and differ between the IFNbeta products in relapsing remitting multiple sclerosis patients.
    Gibbs E, Oger J.
    J Neuroimmunol; 2007 Oct 04; 190(1-2):146-50. PubMed ID: 17825927
    [Abstract] [Full Text] [Related]

  • 19. Neutralizing and binding antibodies to interferon beta in patients with multiple sclerosis: a comparison of assay results from three italian centres.
    Bellomi F, Bramanti P, Trojano M, Scagnolari C, Muto A, Sessa E, La Volpe V, Russo P, Antonelli G.
    J Immunoassay Immunochem; 2009 Oct 04; 30(1):40-50. PubMed ID: 19117201
    [Abstract] [Full Text] [Related]

  • 20. Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis.
    Gilli F, Hoffmann F, Sala A, Marnetto F, Caldano M, Valentino P, Kappos L, Bertolotto A, Lindberg RL.
    Mult Scler; 2006 Dec 04; 12(6):738-46. PubMed ID: 17263001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.